HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2.

AbstractBACKGROUND:
Drug resistance is a major obstacle for the efficacy of chemotherapeutic treatment of tumors. Oct-3/4, a self-renewal regulator in stem cells, is expressed in various kinds of solid tumors including glioblastoma. Although Oct-3/4 expression has been implicated in the malignancy and prognosis of glioblastomas, little is known of its involvement in drug resistances of glioblastoma.
METHODS:
The involvement of Oct-3/4 in drug resistance of glioblastoma cells was assessed by lactate dehydrogenase assay, efflux assay of an anticancer drug, poly ADP-ribose polymerase cleavage, and in vivo xenograft experiments. Involvement of a drug efflux pump ATP binding cassette transporter G2 in Oct-3/4-induced drug resistance was evaluated by quantitative PCR analysis and knockdown by shRNA.
RESULTS:
Oct-3/4 decreased the susceptibility to chemotherapeutic drugs by enhancing excretion of drugs through a drug efflux pump gene, ATP binding cassette transporter G2. Moreover, the expression of Oct-3/4 was well correlated to ATP binding cassette transporter G2 expression in clinical GB tissues.
CONCLUSION:
Oct-3/4 elevated the ATP binding cassette transporter G2 expression, leading to acquisition of a drug-resistant phenotype by glioblastoma cells.
GENERAL SIGNIFICANCE:
If the drug-resistance of glioblastoma cells could be suppressed, it should be a highly ameliorative treatment for glioblastoma patients. Therefore, signaling pathways from Oct-3/4 to ATP binding cassette transporter G2 should be intensively elucidated to develop new therapeutic interventions for better efficacy of anti-cancer drugs.
AuthorsYuki Hosokawa, Hisaaki Takahashi, Akihiro Inoue, Yuya Kawabe, Yu Funahashi, Kenji Kameda, Kana Sugimoto, Hajime Yano, Hironobu Harada, Shohei Kohno, Shiro Ohue, Takanori Ohnishi, Junya Tanaka
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1850 Issue 6 Pg. 1197-205 (Jun 2015) ISSN: 0006-3002 [Print] Netherlands
PMID25644290 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters
  • Antimetabolites, Antineoplastic
  • Neoplasm Proteins
  • Octamer Transcription Factor-3
  • POU5F1 protein, human
  • Doxorubicin
  • L-Lactate Dehydrogenase
  • Poly(ADP-ribose) Polymerases
Topics
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters (metabolism)
  • Animals
  • Antimetabolites, Antineoplastic (metabolism, pharmacology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Dose-Response Relationship, Drug
  • Doxorubicin (metabolism, pharmacology)
  • Drug Resistance, Neoplasm (genetics)
  • Glioblastoma (drug therapy, genetics, metabolism, pathology)
  • Humans
  • L-Lactate Dehydrogenase (metabolism)
  • Male
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Proteins (metabolism)
  • Octamer Transcription Factor-3 (genetics, metabolism)
  • Phenotype
  • Poly(ADP-ribose) Polymerases (metabolism)
  • RNA Interference
  • Signal Transduction
  • Time Factors
  • Transfection
  • Tumor Burden (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: